102 related articles for article (PubMed ID: 8145730)
1. Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene.
Harris PK; Kletzien RF
Mol Pharmacol; 1994 Mar; 45(3):439-45. PubMed ID: 8145730
[TBL] [Abstract][Full Text] [Related]
2. Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent.
Kletzien RF; Foellmi LA; Harris PK; Wyse BM; Clarke SD
Mol Pharmacol; 1992 Oct; 42(4):558-62. PubMed ID: 1435736
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells.
Szalkowski D; White-Carrington S; Berger J; Zhang B
Endocrinology; 1995 Apr; 136(4):1474-81. PubMed ID: 7895657
[TBL] [Abstract][Full Text] [Related]
4. A novel 3T3-L1 preadipocyte variant that expresses PPARgamma2 and RXRalpha but does not undergo differentiation.
Baillie RA; Sha X; Thuillier P; Clarke SD
J Lipid Res; 1998 Oct; 39(10):2048-53. PubMed ID: 9788251
[TBL] [Abstract][Full Text] [Related]
5. Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor gamma ligands.
Rival Y; Stennevin A; Puech L; Rouquette A; Cathala C; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Wurch T; Junquéro D
J Pharmacol Exp Ther; 2004 Nov; 311(2):467-75. PubMed ID: 15273253
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells.
Ibrahimi A; Teboul L; Gaillard D; Amri EZ; Ailhaud G; Young P; Cawthorne MA; Grimaldi PA
Mol Pharmacol; 1994 Dec; 46(6):1070-6. PubMed ID: 7808426
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the murine adipocyte fatty acid transporter gene by insulin.
Man MZ; Hui TY; Schaffer JE; Lodish HF; Bernlohr DA
Mol Endocrinol; 1996 Aug; 10(8):1021-8. PubMed ID: 8843418
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein.
Shaughnessy S; Smith ER; Kodukula S; Storch J; Fried SK
Diabetes; 2000 Jun; 49(6):904-11. PubMed ID: 10866041
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
Kletzien RF; Clarke SD; Ulrich RG
Mol Pharmacol; 1992 Feb; 41(2):393-8. PubMed ID: 1538716
[TBL] [Abstract][Full Text] [Related]
10. The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability.
Sandouk T; Reda D; Hofmann C
Endocrinology; 1993 Jul; 133(1):352-9. PubMed ID: 8319581
[TBL] [Abstract][Full Text] [Related]
11. Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes.
Moldes M; Boizard M; Liepvre XL; Fève B; Dugail I; Pairault J
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):873-80. PubMed ID: 10585876
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes.
Kurebayashi S; Hirose T; Miyashita Y; Kasayama S; Kishimoto T
Diabetes; 1997 Dec; 46(12):2115-8. PubMed ID: 9392507
[TBL] [Abstract][Full Text] [Related]
13. Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP.
Cook JS; Lucas JJ; Sibley E; Bolanowski MA; Christy RJ; Kelly TJ; Lane MD
Proc Natl Acad Sci U S A; 1988 May; 85(9):2949-53. PubMed ID: 2452440
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the murine fatty acid transport protein gene and its insulin response sequence.
Hui TY; Frohnert BI; Smith AJ; Schaffer JE; Bernlohr DA
J Biol Chem; 1998 Oct; 273(42):27420-9. PubMed ID: 9765271
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen CB; Lazar MA
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171
[TBL] [Abstract][Full Text] [Related]
16. Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis.
Wauson EM; Langan AS; Vorce RL
Toxicol Sci; 2002 Feb; 65(2):211-9. PubMed ID: 11812925
[TBL] [Abstract][Full Text] [Related]
17. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo.
Ross SR; Graves RA; Greenstein A; Platt KA; Shyu HL; Mellovitz B; Spiegelman BM
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9590-4. PubMed ID: 2263614
[TBL] [Abstract][Full Text] [Related]
18. CREB activation induces adipogenesis in 3T3-L1 cells.
Reusch JE; Colton LA; Klemm DJ
Mol Cell Biol; 2000 Feb; 20(3):1008-20. PubMed ID: 10629058
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
Tafuri SR
Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of regulation of the 422(aP2) gene by cAMP during preadipocyte differentiation.
Yang VW; Christy RJ; Cook JS; Kelly TJ; Lane MD
Proc Natl Acad Sci U S A; 1989 May; 86(10):3629-33. PubMed ID: 2542943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
